Angueira, C.
31  Ergebnisse:
Personensuche X
?
 
?
3

P476 Effectiveness and safety of ustekinumab in ulcerative ..:

Chaparro, M ; Garre, A ; Iborra, M...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S465-S466 , 2021
 
?
4

P434 Effectiveness and safety of ustekinumab in ulcerative ..:

Chaparro, M ; Garre, A ; Iborra, M...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S394-S395 , 2020
 
?
5

Anti-tumour necrosis factor discontinuation in inflammatory..:

Chaparro, María ; Donday, María G. ; Barreiro-de Acosta, Manuel...
Therapeutic Advances in Gastroenterology.  12 (2019)  - p. 175628481987420 , 2019
 
?
 
?
8

Optimised empiric triple and concomitant therapy forHelicob..:

Molina-Infante, J. ; Lucendo, A. J. ; Angueira, T....
Alimentary Pharmacology & Therapeutics.  41 (2015)  6 - p. 581-589 , 2015
 
?
10

Helicobacter pylori second‐line rescue therapy with levoflo..:

Gisbert, J. P. ; Romano, M. ; Gravina, A. G....
Alimentary Pharmacology & Therapeutics.  41 (2015)  8 - p. 768-775 , 2015
 
?
13

Empiric 6-food elimination diet induced and maintained prol..:

Lucendo, Alfredo J. ; Arias, Ángel ; González-Cervera, Jesús...
Journal of Allergy and Clinical Immunology.  131 (2013)  3 - p. 797-804 , 2013
 
1-15